Phase II/III Study of AZD2816, for the Prevention of COVID-19 in Adults

Trial Identifier: D7220C00001
Sponsor: AstraZeneca
NCTID:: NCT04973449
Start Date: June 2021
Primary Completion Date: February 2022
Study Completion Date: August 2022
Condition: COVID-19 Immunisation

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description
English Version - Booster Vaccine
English Version - Primary Vaccine
Afrikaans (South Africa) Boost Translation
English (UK) Boost Translation
English (South Africa) Boost Translation
Polish Boost Translation
Portuguese (Brazil) Boost Translation
Sotho (South Africa) Boost Translation
Xhosa (South Africa) Boost Translation
Zulu (South Africa) Boost Translation
Afrikaans (South Africa) Naive Translation
English (UK) Naive Translation
English (South Africa) Naive Translation
Polish Naive Translation
Portuguese (Brazil) Naive Translation
Sotho (South Africa) Naive Translation
Xhosa (South Africa) Naive Translation
Zulu (South Africa) Naive Translation

Trial Locations

Country Location
BR Brasilia, BR, 70200-730
BR Curitiba, BR, 80810-050
BR Natal, BR, 59025-050
BR Natal, BR, 59020-035
BR Porto Alegre, BR, 90035-903
BR Salvador, BR, 40110-060
GB Birmingham, GB, B15 2TH
GB Bournemouth, GB, BH7 7DW
GB Bristol, GB, BS105NB
GB Bristol, GB, BS2 8BJ
GB Edinburgh, GB, EH16 4SA
GB Harrow, GB, HA1 3UJ
GB Hull, GB, HU3 2KZ
GB London, GB, NW1 2BH
GB London, GB, E2 0HL
GB London, GB, SE1 9RT
GB London, GB, SE5 9NU
GB Manchester, GB, M8 5RB
GB Newcastle-upon-Tyne, GB, NE1 4LP
GB Nottingham, GB, NG7 2QW
GB Oxford, GB, OX3 7EJ
GB Plymouth, GB, PL6 8DH
GB Portsmouth, GB, PO1 3HN
GB Sheffield, GB, S5 7AU
GB Truro, GB, TR1 3LJ
PL Lublin, PL, 20-362
PL Oświęcim, PL, 32-600
PL Puławy, PL, 24-100
PL Zamosc, PL, 22-400
ZA Bloemfontein, ZA, 9301
ZA Cape Town, ZA, 7500
ZA Johannesburg, ZA, 1818
ZA Johannesburg, ZA, 2092
ZA Johannesburg, ZA, 2013
ZA Somerset West, ZA, 7130